The anti-Xa assay has also been used to successfully monitor UFH efficacy. [11] Levine et al. [10] randomized patients with acute venous thromboembolism who required at least 35,000 units or more of ...
A total of 172 patients were screened to obtain 50 patients in the analysis for each group. The most prevalent reasons for exclusion included heparin infusion for less than 24 hours and inadequate ...
Monitoring unfractionated heparin (UFH) using the activated partial thromboplastin time (APTT) or the anti-factor Xa (anti-Xa) chromogenic assay still seems to be a controversy. Is the anti-Xa less ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results